問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

陳逸群
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2022-07-01 - 2024-09-20

Phase III

Completed
A 6-Week, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Cariprazine in the Acute Exacerbation of Schizophrenia, with an Additional 18-Week Blinded Extension Period
  • Condition/Disease

    Schizophrenia

  • Test Drug

    Cariprazine

Participate Sites
16Sites

Not yet recruiting3Sites

Recruiting11Sites

Terminated2Sites